CASI Pharmaceuticals Inc. (NASDAQ:CASI)’s traded shares stood at 0.85 million during the last session, with the company’s beta value hitting 0.36. At the close of trading, the stock’s price was $0.80, to imply a decrease of -2.04% or -$0.02 in intraday trading. The CASI share’s 52-week high